Latest News

What the New Ahmedabad Hotel Means for Hyatt Hotels (H) Hyatt Hotels (H) has signed an agreement for Hyatt Place Ahmedabad Nikol in India, a 140 room property that extends its presence in Ahmedabad, an important administrative and commercial center. This new Hyatt Place, developed with Golden Buildcon, adds meeting facilities, dining options, and leisure amenities to Hyatt's portfolio in India, giving investors another example of its focus on key gateway cities and emerging markets. See our...

Earlier this week, United Biotechnology and Novo Nordisk reported phase 2 data from China showing that UBT251, a once-weekly triple-agonist for GLP-1, GIP and glucagon, reduced HbA1c and body weight more than semaglutide and placebo in people with type 2 diabetes over 24 weeks. This outperformance versus semaglutide adds a potentially important next-generation obesity and diabetes candidate to Novo Nordisk’s pipeline just as competition, pricing pressure and generic semaglutide emerge in key...

ICL Group (ICL) is back in focus after announcing a new specialty fertilizer facility in Maharashtra, India, aimed at supporting local production as geopolitical tensions disrupt key global shipping routes. See our latest analysis for ICL Group. Despite the India expansion headlines, ICL's recent share price moves have been subdued, with a 7 day share price return of a 4.28% decline and a year to date share price return of an 11.05% decline, while the 5 year total shareholder return sits at...

ADP Research released a new global workforce study highlighting widespread job insecurity among employees worldwide. Only 22% of workers surveyed said they are strongly confident their jobs are secure, despite low unemployment levels. The report flags higher concern among lower paid, repetitive roles and lower management positions. Automatic Data Processing (NasdaqGS:ADP), trading at around $204.89, is coming off a challenging stretch, with the share price down 19.0% year to date and 29.8%...

What Apogee Therapeutics stock has been doing recently Apogee Therapeutics (APGE) has seen mixed share performance recently, with a 7% gain over the past month, a 6% decline over the past 3 months, and a 4% negative return year to date. See our latest analysis for Apogee Therapeutics. At a share price of $73.0, Apogee Therapeutics has seen short term volatility, with a 1 day share price return of negative 7.87%, but a 1 year total shareholder return of 83% points to stronger longer term...

Investors may be wondering whether Brown-Forman is starting to look attractively priced, or if recent weakness is just a value trap in disguise. The stock closed at US$22.80, with returns of a 1.5% decline over 7 days, 24.0% decline over 30 days, 12.8% decline year to date, 30.1% decline over 1 year, 61.2% decline over 3 years, and 63.9% decline over 5 years, which may have changed how the market views its risk and potential. Recent coverage has focused on Brown-Forman's share price pressure...

Cutia Therapeutics (SEHK:2487) opened FY 2025 with first half revenue of C¥66.3 million and a basic EPS loss of C¥0.75, while trailing twelve month revenue sat at C¥336.2 million against a basic EPS loss of C¥1.03. The company reported revenue of C¥95.6 million in the first half of 2024, C¥184.0 million in the second half of 2024, and C¥66.3 million in the first half of 2025, with basic EPS losses of C¥0.66, C¥0.75 and C¥0.75 over those same periods. This sequence highlights that investors...

In March 2026, U.S. prosecutors indicted three people connected to Super Micro Computer, including co-founder Yih-Shyan “Wally” Liaw, over alleged illegal exports of Nvidia-powered AI servers to China, prompting his resignation from the board and the appointment of DeAnna Luna as acting Chief Compliance Officer. This enforcement action highlights how export-control compliance and governance practices can quickly become as important to Super Micro’s investment case as its AI server growth...

AsiaInfo Technologies (SEHK:1675) has opened FY 2025 with first half revenue of C¥2.6b and a basic EPS loss of C¥0.22, setting a cautious tone for investors watching how the recent slowdown in profitability plays through the rest of the year. The company has seen first half revenue move from C¥3.0b in 2024, when EPS was a loss of C¥0.06, to C¥2.6b in 2025 alongside a trailing twelve month EPS of C¥0.13, leaving the latest results framed by thin margins and plenty of focus on how quickly...

Ondas FY 2025 results set the stage for a tighter focus on profitability Ondas (ONDS) just posted its FY 2025 numbers with third quarter revenue at about US$10.1 million and a basic EPS loss of US$0.03, alongside trailing twelve month revenue of roughly US$24.7 million and a cumulative net loss of about US$47.7 million. Over recent quarters, the company has seen revenue move from around US$0.96 million in Q2 2024 to US$1.48 million in Q3 2024, then to US$4.25 million in Q1 2025, US$6.27...

Dongguang Chemical (SEHK:1702) has posted its FY 2025 results with first half revenue of CNY 1.2b and basic EPS of CNY 0.12, while trailing twelve month revenue came in at CNY 2.4b with basic EPS of CNY 0.23, set against a 65.5% earnings rise and a net profit margin of 5.9% for the period. Over recent periods the company has seen revenue move from CNY 1.34b in 2024 H1 to CNY 1.24b in 2024 H2 and CNY 1.18b in 2025 H1. Basic EPS shifted from CNY 0.15 in 2024 H1 to a small loss in 2024 H2 and...

Fox-Wizel (TASE:FOX) has wrapped up FY 2025 with fourth quarter revenue of ₪2.1b and basic EPS of ₪7.47, while trailing twelve month revenue stands at ₪7.1b and EPS at ₪16.54, setting a clear benchmark for how the business is currently earning its shekel. Over recent periods, revenue has moved from ₪6.4b in the trailing twelve months to Q4 2024 to ₪7.1b in the latest trailing period, with quarterly basic EPS ranging from ₪1.10 in Q1 2025 to ₪8.41 in Q4 2024 and ₪7.47 in Q4 2025. As a result,...

Antares Vision (BIT:AV) has reported its FY 2025 first half with revenue of €90.4 million and a basic EPS loss of €0.18, setting a cautious tone around profitability. The company has seen revenue move from €86.97 million in 1H 2024 to €120.7 million in 2H 2024 and then €90.4 million in 1H 2025, while EPS shifted from a €0.31 loss in 1H 2024 to a €0.05 profit in 2H 2024 before returning to a €0.18 loss in the latest period, leaving margins under clear pressure. See our full analysis for...

Oscar Health, NYSE:OSCR, is shifting its business toward a scalable healthcare platform with broader national reach. The company is reporting clearer signs of operational improvement, including operating margin and efficiency gains. Oscar Health is using its balance sheet to support expansion and build what looks increasingly like infrastructure for healthcare delivery. Oscar Health, NYSE:OSCR, is getting attention for its business model shift rather than just its share price, which closed...

As the Australian market navigates a topsy-turvy landscape marked by rising oil prices and geopolitical tensions, the ASX 200 is showing signs of resilience with a positive start. Amidst this backdrop, dividend stocks continue to attract attention for their potential to provide steady income streams, especially in uncertain times.

Earlier in March 2026, Integer Holdings Corporation expanded its Board of Directors to 13 members by appointing James F. Flanagan, former PwC Chief Operating Officer, and activist investor representative Aaron Kapito under a Cooperation Agreement with Irenic Capital Management. The agreement, which includes committee assignments, voting commitments, standstill restrictions, and future board size limits, signals an effort to refresh governance and respond to shareholder concerns about...

Royal Caribbean stock reacts to strong results and rising cost risks Royal Caribbean Cruises (RCL) is in focus after robust 2025 earnings, firm 2026 guidance, and a reinstated dividend met growing worries about fuel costs, heavy 2026 debt maturities, and planned capital spending. At the same time, high advance bookings at record pricing and commentary about potential margin pressure are encouraging investors to reassess what they are willing to pay for the stock following several years of...

As the Australian market navigates a turbulent landscape with rising oil prices and geopolitical tensions, optimism persists with early ASX 200 futures pointing to a green open. In such uncertain times, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closest to the business, potentially offering resilience amid market fluctuations.

INFICON Holding FY 2025 Earnings Snapshot INFICON Holding (SWX:IFCN) has posted its FY 2025 results with second half revenue of US$348.0 million and basic EPS of US$1.74, alongside net income of US$42.6 million, setting the tone for how the year closed out. The company has seen revenue move from US$349.8 million and basic EPS of US$2.48 in 2H 2024 to US$348.0 million and US$1.74 in 2H 2025, while trailing twelve month revenue sits at US$673.7 million with EPS of US$3.51, giving a clear read...

Why Valley National Bancorp (VLY) is on investor radar today Valley National Bancorp (VLY) is drawing attention after recent share price moves, with the stock up 2.3% over the past day and 3.1% over the past week, in contrast to a one-month decline of 8.2%. See our latest analysis for Valley National Bancorp. Zooming out from the latest move, VLY's recent 1 month share price pullback contrasts with a stronger year to date share price return and a 1 year total shareholder return of 40.4%. This...

Transgene (ENXTPA:TNG) has opened FY 2025 with first half revenue of €4.6 million and a basic EPS loss of €0.15, alongside a net income loss of €19.3 million. Over the past three reported half year periods, revenue has moved from €3.4 million in H1 2024 to €3.0 million in H2 2024 and now €4.6 million in H1 2025. Basic EPS losses over those same halves were €0.16, €0.13 and €0.15 respectively, against trailing twelve month revenue of €7.2 million and a net income loss of €37.5 million. With...

Viridien Société anonyme (ENXTPA:VIRI) has moved to redeem $40,660,000 of its $406,600,000 outstanding notes at 103% of principal, plus $1,818,405.56 in accrued interest, drawing attention to its debt profile. See our latest analysis for Viridien Société anonyme. The planned note redemption comes at a time when the share price, last closing at €133.1, has shown strong momentum, with a 30 day share price return of 12.42% and a 90 day share price return of 40.70%. The 1 year total shareholder...

GameStop signaled a potential exit from its French operations alongside its latest quarterly earnings release. The company reported results that beat earnings expectations and confirmed a greater focus on trading cards and collectibles. GameStop disclosed a cash and marketable securities position of about $9b, creating capacity for possible acquisitions. CEO Ryan Cohen did not provide forward guidance, keeping plans for any future deals unspoken. For investors tracking NYSE:GME, the share...

As the Australian market navigates a topsy-turvy landscape with rising oil prices and geopolitical tensions, optimism persists with ASX 200 futures showing early gains despite ongoing inflation concerns. In this environment, high growth tech stocks can offer potential for portfolio expansion by leveraging innovation and market demand to capitalize on current economic conditions.